EVO ICL FAQ: Your Questions Answered
This EVO ICL FAQ guide is designed for patients in Andover, MA, and throughout the greater Boston area who are exploring vision correction options beyond LASIK. Whether you are curious about candidacy, the procedure itself, recovery, or cost, this page addresses the questions our team hears most often. The ophthalmologists at Boston Vision provide answers grounded in clinical experience and published research. Read through, then take the next step toward clearer vision.
Schedule your EVO ICL consultation at Boston Vision today.
Frequently Asked Questions About EVO ICL: Your Questions Answered in Andover, MA
What is EVO ICL, and how is it different from LASIK?
EVO ICL is an implantable collamer lens placed inside the eye, between the natural lens and the iris, to correct nearsightedness and astigmatism. Unlike LASIK eye surgery, which permanently reshapes the corneal surface using a laser, EVO ICL does not remove any corneal tissue. This additive approach may be especially beneficial for patients with thinner corneas or dry eye concerns. The lens is also removable by a surgeon if vision needs change over time, though it is designed to remain in place long term. Individual results may vary.
How does EVO ICL work to correct vision?
The EVO ICL lens is made from Collamer, a biocompatible material containing collagen that the body tolerates well. Once placed inside the eye through a small incision, it works like a permanent contact lens, focusing light precisely onto the retina to reduce or eliminate the need for glasses or contact lenses. The lens incorporates a central port that allows natural fluid to flow freely, which supports healthy intraocular pressure. Most patients notice improved vision very shortly after their procedure, though the full stabilization of results may take a short period. Individual results may vary.
What conditions or prescriptions can EVO ICL help address?
EVO ICL is FDA-approved for the correction of myopia (nearsightedness) ranging from -3.0 to -20.0 diopters, with or without astigmatism up to 4.0 diopters. It may be a suitable option for patients whose prescriptions fall outside the typical range recommended for laser procedures such as LASIK or PRK laser eye surgery. Patients who have been told they are not candidates for cornea-based refractive surgery are often excellent candidates for EVO ICL. A comprehensive evaluation with one of our surgeons will determine whether your prescription and eye anatomy align well with this lens.
Am I a good candidate for EVO ICL?
Good candidates are typically between 21 and 45 years of age, have a stable prescription, and have sufficient anterior chamber depth to safely accommodate the lens. Patients with thin corneas, mild to moderate dry eye, or high prescriptions who did not qualify for laser correction may find EVO ICL to be a well-suited alternative. Conditions such as active eye disease, certain anterior segment abnormalities, or inadequate chamber dimensions may affect candidacy. The only way to know for certain is through a thorough diagnostic evaluation. You can also begin exploring your options with our vision correction self-test before your consultation.
Who at Boston Vision performs EVO ICL procedures?
EVO ICL procedures at Boston Vision are performed by fellowship-trained, board-certified ophthalmologists with subspecialty expertise in corneal and refractive surgery. Dr. Samir Melki, the practice founder and a charter fellow of the World College of Refractive Surgery, and Dr. Jason Brenner, a staff surgeon at Beth Israel Deaconess Medical Center and part-time lecturer at Harvard Medical School, lead the refractive surgery program. Drs. Gregoire and Keshav, both fellowship-trained in cornea and refractive surgery, also contribute to patient care. You can learn more about the full team on our Meet Our Doctors page.
What should I expect at my EVO ICL consultation?
Your consultation includes a comprehensive set of diagnostic measurements: corneal topography, anterior chamber depth assessment, pupil size evaluation, and a full refraction. You will meet one-on-one with your treating surgeon, who will review your results, discuss your visual goals, and determine whether EVO ICL is the most appropriate option for your eyes. At Boston Vision, patients have direct access to their surgeon throughout the process, including a direct line of contact after the procedure. This personalized approach distinguishes a private academic medicine practice from a high-volume commercial center. Plan for the appointment to take approximately two hours.
How long does the EVO ICL procedure take, and what is the experience like?
The surgical portion of the EVO ICL procedure typically takes approximately 20 to 30 minutes per eye. The procedure is performed under topical anesthesia, meaning eye drops are used rather than injections, and most patients report feeling minimal discomfort during the process. A small incision is created at the corneal edge, the lens is inserted and centered, and the incision self-seals without sutures in most cases. Boston Vision uses blade-free and advanced imaging technology to support precision and predictability. Patients are driven home the same day and asked to rest for the remainder of that day.
What is the recovery like after EVO ICL surgery?
Most patients notice a meaningful improvement in vision within the first 24 hours following surgery. Mild light sensitivity, halos around lights, and mild blurring are common in the first few days and typically resolve as the eye settles. Patients are generally advised to avoid swimming, contact sports, and rubbing the eyes for a period following surgery, as directed by their surgeon. Most people are able to return to everyday activities within a day or two, though the specific recovery timeline may vary. Individual results may vary, and your surgeon will provide a personalized recovery plan based on your procedure and eye health.
Is EVO ICL safe, and what are the potential risks?
EVO ICL has been studied in clinical trials for over a decade and is FDA-approved for its indicated uses. As with any surgical procedure, there are potential risks, including elevated intraocular pressure, cataract formation, halos or starbursts, and, rarely, the need for lens removal or replacement. The central port design of the current EVO model was developed specifically to reduce the risk of pressure-related complications seen in earlier lens designs. At Boston Vision, strict safety protocols and standardized measurement practices are used to minimize risk and allow for predictable outcomes. A thorough discussion of your personal risk profile will take place during your consultation.
What factors influence the cost of EVO ICL in Andover, MA?
The cost of EVO ICL varies based on several factors, including the complexity of your prescription, the diagnostic workup involved, the specific lens selected, and any follow-up care required. Because EVO ICL is considered an elective refractive procedure, it is not typically covered by insurance. Boston Vision offers financing options to help patients plan for the investment in their vision. Rather than quoting a fee before a full evaluation, we encourage you to schedule a consultation so your surgeon can provide a complete and accurate estimate based on your individual needs. Comparing this EVO ICL FAQ to LASIK affordability information may also be helpful: see our LASIK eye surgery cost page for context on how refractive procedure pricing is structured.
Do you serve patients traveling from Andover and the surrounding communities?
Yes. Boston Vision welcomes patients from Andover, North Andover, Lawrence, Haverhill, Methuen, and communities throughout the Merrimack Valley and greater Boston region. With seven locations across the area, access to consultation, surgery, and follow-up care is convenient regardless of where you live. Many patients choose to have their surgery performed at one location and follow-up appointments at a location closer to home. You can view the full list of available locations on our Boston Vision locations page to find the office most accessible to you.
What makes Boston Vision a distinct choice for EVO ICL in the Andover, MA area?
Boston Vision operates as a private academic medicine practice, a model that is uncommon in the refractive surgery space. The surgeons publish original research, teach at Harvard Medical School-affiliated programs, and apply academic rigor to every clinical decision. Dr. Melki has performed refractive and corneal procedures internationally, including artificial cornea implantation in the Middle East, and the team as a whole brings a level of subspecialty depth that goes beyond what most refractive practices offer. Patients also benefit from direct surgeon access throughout their entire care experience. To hear from patients who have experienced this firsthand, visit our patient reviews page.
Why Choose Boston Vision for EVO ICL?
Boston Vision was founded in 2000 by Dr. Samir Melki, whose training at Massachusetts Eye and Ear Infirmary and ongoing faculty role at Harvard Medical School set the academic standard that the entire practice upholds. Dr. Jason Brenner brings additional depth as a staff surgeon at Beth Israel Deaconess Medical Center and an active researcher in corneal and refractive surgery. Together, they lead a team where every surgeon has completed subspecialty fellowship training. For patients in Andover, MA seeking EVO ICL from a team that combines clinical rigor, published expertise, and genuine personal attention, Boston Vision offers a level of care that is uncommon in refractive surgery. Seven convenient locations across the greater Boston area make ongoing access straightforward.
Ready to Learn Whether EVO ICL Is Right for You?
If this EVO ICL guide has helped clarify your options, the next step is a one-on-one consultation with a fellowship-trained surgeon at Boston Vision, serving Andover, MA, and the surrounding region. Call us to get started or book your consultation online. Our team is ready to help you make an informed, confident decision about your vision.
